Health Care & Life Sciences » Biotechnology | Catabasis Pharmaceuticals Inc.

Catabasis Pharmaceuticals Inc.

Catabasis Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.25
Market Cap
$85.76 M
Shares Outstanding
11.5 M
Public Float
10.43 M

Profile

Address
One Kendall Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.catabasis.com
Updated 07/08/2019
Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of therapeutics for the treatment of cardiovascular, metabolic and inflammatory diseases. The company was founded by Jill C.

Financials

View All

Jill C. Milne
President, Chief Executive Officer & Director
Burt A. Adelman
Director